150 related articles for article (PubMed ID: 7470395)
1. An evaluation of chromogenic substrates in the control of oral anticoagulant therapy.
Latallo ZS; Thomson JM; Poller L
Br J Haematol; 1981 Feb; 47(2):307-18. PubMed ID: 7470395
[TBL] [Abstract][Full Text] [Related]
2. An assessment of an amidolytic assay for factor VII in the laboratory control of oral anticoagulants.
Poller L; Thomson JM; Bodzenta A; Easton AC; Latallo ZS; Chmielewska J
Br J Haematol; 1981 Sep; 49(1):69-75. PubMed ID: 7272230
[TBL] [Abstract][Full Text] [Related]
3. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
[TBL] [Abstract][Full Text] [Related]
4. Comparison between British Comparative Thromboplastin (BCT) and a factor II-VII-X determination method (simplastin A) based on fresh plasma samples from dicoumarol-treated patients.
Korsan-Bengtsen K; Johsen M; Pehrsson NG
Thromb Haemost; 1977 Feb; 37(1):98-103. PubMed ID: 65801
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulant control with a chromogenic substrate: calibration, precision and cost.
Famodu AA; Ingram GI
Clin Lab Haematol; 1982; 4(1):27-39. PubMed ID: 7067373
[TBL] [Abstract][Full Text] [Related]
6. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
Chmielewska J; Latallo ZS
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
[TBL] [Abstract][Full Text] [Related]
7. Further evaluation of an automated amidolytic factor X assay in monitoring anti-vitamin K treatment.
van Wijk EM; Kahlé LH; Jeletich A; ten Cate JW
Scand J Haematol; 1982 Aug; 29(2):105-14. PubMed ID: 6813960
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new chromogenic assay for factor VII and its application in patients on oral anticoagulant treatment.
Avvisati G; ten Cate JW; van Wijk EM; Kahlé LH; Mariani G
Br J Haematol; 1980 Jun; 45(2):343-52. PubMed ID: 7437329
[TBL] [Abstract][Full Text] [Related]
9. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
Hjorth B; Kjaersgaard E
Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
[TBL] [Abstract][Full Text] [Related]
10. A clinical evaluation of automated chromogenic tests as substitutes for conventional prothrombin time and activated partial thromboplastin time tests.
Duncan A; Bowie EJ; Owen CA; Fass DN
Clin Chem; 1985 Jun; 31(6):853-5. PubMed ID: 3995763
[TBL] [Abstract][Full Text] [Related]
11. Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X.
Erskine JG; Walker ID; Davidson JF
J Clin Pathol; 1980 May; 33(5):445-8. PubMed ID: 7400342
[TBL] [Abstract][Full Text] [Related]
12. How to measure factor VII and factor VII activation.
Osterud B
Haemostasis; 1983; 13(3):161-8. PubMed ID: 6350121
[TBL] [Abstract][Full Text] [Related]
13. [Blood coagulation monitoring in oral anticoagulant therapy using chromogenic substances].
Pindur G; Seifried E; Joos A; Rasche H
Med Lab (Stuttg); 1981; 34(3):88-91. PubMed ID: 7231353
[No Abstract] [Full Text] [Related]
14. [Monitoring anticoagulant treatment with the KEM-O-MAT 2HP autoanalyzer].
Laharrague P; Leleu T; Poignot JL; Cambus JP; Biermé R
Nouv Rev Fr Hematol (1978); 1983; 25(2):107-12. PubMed ID: 6866753
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation in liver diseases of a new blood coagulation test for the determination of factors II, VII and X].
Pagliano FM; Cestari G; Slucca P
Arch Sci Med (Torino); 1976; 133(4):315-20. PubMed ID: 1023839
[TBL] [Abstract][Full Text] [Related]
16. Maintenance control of oral anticoagulant therapy by an automated chromogenic substrate assay of factor X.
Erskine JG; Walker ID; Davidson JF
Clin Lab Haematol; 1982; 4(2):179-86. PubMed ID: 7116798
[TBL] [Abstract][Full Text] [Related]
17. Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin.
Smith SA; Comp PC; Morrissey JH
J Thromb Haemost; 2006 Jul; 4(7):1553-8. PubMed ID: 16839353
[TBL] [Abstract][Full Text] [Related]
18. Use of a centrifugal analyzer in coagulation testing.
Hills LP; Lorenzi-Anderson M; Huey EE; Tiffany TO
Semin Thromb Hemost; 1983 Jul; 9(3):217-27. PubMed ID: 6612352
[No Abstract] [Full Text] [Related]
19. Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest.
Girolami A; Saggin L; Gazzetta R; Saltarin P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):610-6. PubMed ID: 6170557
[TBL] [Abstract][Full Text] [Related]
20. A circulating anticoagulant specific for factor V.
Handley DA; Duncan BM
Pathology; 1969 Oct; 1(4):265-72. PubMed ID: 5406477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
